HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein. [PDF]
EBioMedicine, 2022 Liu Z +12 more
europepmc +1 more source
Evaluation of Platelet Activation by HIV Protease Inhibitors - The HIV-PLA II Study. [PDF]
HIV AIDS (Auckl), 2021 Kann G +8 more
europepmc +1 more source
Revista da Sociedade Brasileira de Medicina Tropical, 2011 INTRODUCTION: HIV-infected children and adolescents treated with highly active antiretroviral therapy (HAART) regimens that include a protease inhibitor (PI) can show significant improvements in clinical outcomes, nutritional status and quality of life ...
Marina Hjertquist Tremeschin +5 more
doaj
HIV protease: late action to prevent immune detection. [PDF]
Signal Transduct Target Ther, 2021 Sparrer KMJ, Kirchhoff F.
europepmc +1 more source
Short-Term Administration of HIV Protease Inhibitor Saquinavir Improves Skull Bone Healing with Enhanced Osteoclastogenesis. [PDF]
Plast Reconstr Surg, 2022 Liu H +9 more
europepmc +1 more source
Semi-quantification and Potency Verification of the HIV Protease Inhibitor Based on the Matrix-Capsid Protein Immobilized Nickel (II)/NTA-Tol/Graphene Oxide/SPCE Electrochemical Biosensor. [PDF]
ACS Omega, 2023 Thongkum W +7 more
europepmc +1 more source
Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17. [PDF]
J Mol Graph Model, 2021 Burnaman SH +4 more
europepmc +1 more source
Suspected bradycardia due to interactions between HIV protease inhibitors and lidocaine: a case report. [PDF]
J Dent Anesth Pain Med, 2021 Hamaya E, Kamekura N, Fujisawa T.
europepmc +1 more source
Evolution of drug resistance in HIV protease. [PDF]
BMC Bioinformatics, 2020 Shah D, Freas C, Weber IT, Harrison RW.
europepmc +1 more source